Nature Communications (Apr 2020)

Chronic activation of hexosamine biosynthesis in the heart triggers pathological cardiac remodeling

  • Diem Hong Tran,
  • Herman I. May,
  • Qinfeng Li,
  • Xiang Luo,
  • Jian Huang,
  • Guangyu Zhang,
  • Erica Niewold,
  • Xiaoding Wang,
  • Thomas G. Gillette,
  • Yingfeng Deng,
  • Zhao V. Wang

DOI
https://doi.org/10.1038/s41467-020-15640-y
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 15

Abstract

Read online

Metabolic remodeling plays an important role in pathological cardiac hypertrophy. Here, the authors show that hexosamine biosynthetic pathway is elevated in the heart by pressure overload, which contributes to heart failure by persistent activation of mTOR.